Abstract
Biomanufacturing In article number 2100073, Mehdi Kazemzadeh-Narbat, Ali Tamayol, and co-workers emphasize on the fabrication strategies for bone tissue engineering and their United States Food and Drug Administration regulatory perspective. Bone biology and materials for engineering bone grafts are discussed. (Bio)manufacturing approaches are critically reviewed. Subsequently, a road map for United States Food and Drug Administration conformance is provided.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call